Skip to main content
Clinical Trials/JPRN-UMIN000024859
JPRN-UMIN000024859
Completed
未知

The effectiveness of motor and psychiatric symptoms for Parkinson's disease patients by switching from Dopamine agonist to Zonisamide or combining Dopamine agonist and Zonisamide. - The effectiveness of motor and psychiatric symptoms for Parkinson's disease patients by switching from Dopamine agonist to Zonisamide or combining Dopamine agonist and Zonisamide.

Medical Corporation Abe Neurology Clinic0 sites50 target enrollmentNovember 16, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Parkinson&#39
Sponsor
Medical Corporation Abe Neurology Clinic
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 16, 2016
End Date
August 18, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Medical Corporation Abe Neurology Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients who have taken zonisamide within 6 months from the start of study drug administration
  • 2\)Patients with cognitive impairment of MMSE score 23 or less
  • 3\)Patients who have undergone surgical therapy for parkinsonism, including stereotactic neurosurgery
  • 4\)Pregnant or possibly pregnant women, women of childbearing potential who do not agree to use appropriate contraceptive measures, or breast\-feeding women
  • 5\)Patients who, in the opinion of the investigator or other study personnel, are unsuitable for the study

Outcomes

Primary Outcomes

Not specified

Similar Trials